AC Immune (ACIU) Net Income towards Common Stockholders (2015 - 2026)
AC Immune's Net Income towards Common Stockholders was -$16.36 million in the quarter ended Jun 30, 2026, compared with -$25.59 million a year earlier.
Powered by 
Analysis
AC Immune (ACIU) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, AC Immune's Net Income towards Common Stockholders was -$54.16 million through Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$84.97 million.
- In earlier years, Net Income towards Common Stockholders was -$57.88 million in the year ended Dec 31, 2024, -$60.39 million in the year ended Dec 31, 2023, -$891.04 in the year ended Dec 31, 2022 and -$1,062 in the year ended Dec 31, 2021.
- Quarterly Net Income towards Common Stockholders has moved between -$61.14 million (the quarter ended Dec 31, 2023) and $53.98 million (the quarter ended Dec 31, 2022) over five years.
- Per Business Quant data, ACIU's Net Income towards Common Stockholders in the three quarters before the quarter ended Jun 30, 2026 was -$191.55 (quarter ended Mar 31, 2026), -$17.98 million (quarter ended Dec 31, 2025) and -$19.82 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | AC Immune | 276.74 Mn | 276.74 Mn | - | -16.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.36 Mn |
| Mar 31, 2026 | -191.55 |
| Dec 31, 2025 | -17.98 Mn |
| Sep 30, 2025 | -19.82 Mn |
| Jun 30, 2025 | -25.59 Mn |
| Mar 31, 2025 | -211.33 |
| Dec 31, 2024 | -18.03 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | -25.17 Mn |
| Mar 31, 2024 | -206.22 |
| Dec 31, 2023 | -61.14 Mn |
| Sep 30, 2023 | -203.79 |
| Jun 30, 2023 | -222.44 |
| Mar 31, 2023 | -227.04 |
| Dec 31, 2022 | 53.98 Mn |
| Sep 30, 2022 | -14.00 Mn |
| Jun 30, 2022 | -238.81 |
| Mar 31, 2022 | -249.05 |
| Dec 31, 2021 | -281.97 |
| Sep 30, 2021 | -239.61 |
API Access
AC Immune Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();